![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
Title
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
Phase ![sort descending](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/arrow_down.gif)
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
Protocol
IDs
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
UKALL2003
NCT00222612
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
2005-000658-56
20040177, 2004-41-4276, NCT00192673
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Study Treatment to Low Risk ALL
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
LAL-BR/2001
NCT00526175
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
LAL-Ph-2000
NCT00526305
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
LAL-AR-N-2005
NCT00526409
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase IV
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
2006-00055-18
NCT00415103
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
RPCI-RP-9815
NCI-V99-1527, NCT00003816, RP 98-15
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Levosta-CBF-02/04
NCT00215007
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Stem Cell Transplantation for Hematological Malignancies
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
0005M52481
MT2000-12, NCT00176839
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children (ESPHALL)
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
Phase III, Phase II
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
EUDRACT 2004-001647-30
PHRC/04-04, CIC0203/043, NCT00287105
![](https://webarchive.library.unt.edu/eot2008/20090201130750im_/http://www.cancer.gov/images/spacer.gif)
|
|